Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00424385
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2007-01-17
Brief Title:
Study Combining Imatinib Mesylate Gleevec With Sorafenib in Patients With Androgen-independent Prostate Cancer AIPC
Sponsor:
Oncology Specialists SC
Organization:
Oncology Specialists SC
Organization Data
Organization:
Oncology Specialists SC
Class:
OTHER
Study ID:
CST1571BUS260 0617
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Oncology Specialists SC
Lead Sponsor Class:
OTHER
Responsible Party:
Dr Sigrun Hallmeyer
Responsible Party Title:
Principal Investigator
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Oncology Specialists SC
Old Name:
None
Old Organization:
None